Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 9 lip 2021 · Given the dependency of children upon adults with regard to pain assessment, prevention, and treatment, children 0-17 years are a vulnerable population and in need of special attention with regard to pain management. Pain experiences, including acute and chronic, are common in infants, children, and adolescents.

  2. key sociodemographic and psychosocial correlates of chronic pain in children and adolescents is needed. This manuscript outlines a protocol for a systematic review to update a prior review synthesising the published literature on the prevalence of chronic pain in children and adoles-cents. Specifically, the objectives of this review are to: (1)

  3. 22 gru 2020 · These guidelines focus on physical, psychological and pharmacological interventions for the management of primary and secondary chronic pain in children 0 to 19 years of age.

  4. 14 wrz 2011 · Key points. Chronic pain in childhood is a significant health problem. Long-term nociceptive and neuropathic pain does occur in children, but underlying mechanisms, treatment, and prognosis are influenced by age. Co-existing functional impairment and psychological symptoms such as anxiety and low mood are important co-morbidities.

  5. 2 sty 2021 · Chronic pain or pain that persists or recurs for longer than three months in children is a significant public health problem and a leading cause of morbidity in children globally. Without access to pain management, the quality of life for children and adolescents with chronic pain is severely impacted.

  6. Chronic pain is generally defined as any continuous or recurrent pain lasting more than 12 weeks, or pain that persists beyond the normal expected time for tissue healing; causes may be postinjury, disease-related or idiopathic.

  7. Key points. •. All pain, whether acute or persistent, is biopsychosocial in its presentation and management. •. Early introduction of biopsychosocial management principles is recommended to improve adherence to treatment and clinical outcomes. •.